In conclusion, early in-hospital Sac/Val therapy initiation, in addition to contemporary recommended HF therapy, triggered a greater NT-proBNP level reduction, without increasing AE risk, in stabilized Japanese patients after an AHF event. This evidence concerns the gene NPPB and hydrops fetalis.